DV
Dividend Vision

ALDX — Aldeyra The

Aldeyra The (ALDX)

Total return is -78.3% over the past 12.3 years, 485.6 points behind SPY at 407.3%. Its deepest 1-year drawdown was 78.9%.

This equity fund focuses on stock holdings within the healthcare or biotechnology sector. With limited publicly available distribution data and no current yield profile, the fund appears oriented toward capital appreciation rather than income generation. The fund may appeal to growth-oriented investors seeking equity exposure to specialized healthcare or therapeutic development companies.

ALDX key facts

Asset type
Stock
Asset class
Equity
Inception date
05/02/2014
Last close
$1.56
Market cap
$101,942,608
Average volume
830000.0
Beta
1.152
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.45